The Patent Finder
US

Composition and Dosage Form Comprising an Interferon Particle Formulation and Suspending Vehicle

US 7,731,947 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 22, 2028 · High confidence

Filed Nov 15, 2004 as application 10/988,716 · Granted Jun 8, 2010
Base term plus 1284 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2004 2028
Clock starts
Nov 15, 2004
Term ends
May 22, 2028
Granted
Jun 8, 2010
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,284
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1284 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 15, 2004, when this application, 10/988,716, was filedNov 15, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1284 days, USPTO patent term adjustment recordMay 22, 2028High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 22, 2028High confidence

This family

Application 10/742,730Abandoned
not computed
not computed
US 7,731,947this patent
May 2028
May 2028
Application PCT/US2004/038409PCT application
no patent term
no patent term
Application 12/315,194Abandoned
not computed
not computed
US 7,964,183Term ended
Nov 2024
Nov 2024
US 8,257,691Term ended
Nov 2024
Nov 2024
US 8,398,967Term ended
May 2024
May 2024
US 9,724,293Lapsed on the fee record
Aug 2021
Aug 2021
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 19, 2005
Reel 15594, frame 243
Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, GunjanAlza CorporationAssignment of Assignor's Interest
Dec 13, 2007
Reel 20252, frame 143
Alza CorporationIntarcia Therapeutics, Inc.Assignment of Assignor's Interest
Sep 8, 2010
Reel 24953, frame 525
Intarcia Therapeutics, Inc.Oxford Finance Corporation; Silicon Valley BankSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Oxford Finance CorporationSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Silicon Valley BankSecurity Agreement
Sep 23, 2011
Reel 26962, frame 62
Oxford Finance Corporation; Silicon Valley BankIntarcia Therapeutics, Inc.Release of Security Interest
Nov 14, 2012
Reel 29299, frame 678
Intarcia Therapeutics, Inc.U.S. Bank National Association, as Collateral AgentSecurity Agreement
Oct 23, 2015
Reel 36942, frame 544
U.S. Bank National Association, as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Oct 9, 2019
Reel 50673, frame 20
Intarcia Therapeutics, Inc.; Intarcia Ireland LimitedMidcap Financial Trust, As AgentSecurity Interest
Oct 23, 2019
Reel 50801, frame 267
Intarcia Therapeutics, Inc.Baupost Private Investments Bviv-3, L.L.C., as Collateral AgentSecurity Interest
Jan 29, 2020
Reel 51739, frame 453
Baupost Private Investments Bviv-3, L.L.C. as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
Reel 52433, frame 1
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.; Intarcia Ireland LimitedRelease of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited